Management of COVID-19 in 55 hemodialysis patients: Experience from Eastern Turkey
Özet
Aim: The novel coronavirus causes acute severe respiratory syndrome (SARS COV 2), and the disease is named COVID-19. The virus spreads easily, and COVID-19 may be asymptomatic or cause severe pneumonia and ARDS. Hemodialysis patients are affected by COVID-19 because of the immunosuppression caused by uremia, comorbid diseases and the risk of cross-contamination during dialysis. In this study, we aimed to examine the clinical features and outcomes of 55 hemodialysis patients diagnosed with COVID-19.
Sürdürülebilir Kalkınma Amaçları
-
SKA 3: Sağlıklı Bireyler
Atıf için künye
Sevinç, C., Timur, O., Utlu, M., & Çankaya, E. (2021). Management of COVID-19 in 55 hemodialysis patients: Experience from Eastern Turkey. ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 12(4), 438–442. https://doi.org/10.4328/acam.20508
BibTeX
@article{sevinc2021-243677,
author = {Sevinç, Can and Timur, Ozge and Utlu, Mustafa and Çankaya, Erdem},
title = {Management of COVID-19 in 55 hemodialysis patients: Experience from Eastern Turkey},
journal = {ANNALS OF CLINICAL AND ANALYTICAL MEDICINE},
year = {2021},
volume = {12},
number = {4},
pages = {438--442},
issn = {2667-663X},
doi = {10.4328/acam.20508},
url = {https://akademik.atauni.edu.tr/yayinlar/243677-management-of-covid-19-in-55-hemodialysis-patients-experience-from-eastern}
}